Loading...
Market
Will the FDA approve the BiVACOR titanium heart for general use by the end of 2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
FDA official announcements, BiVACOR press releases
Story
Doctors Successfully Implant BiVACOR Titanium Heart Using Maglev Technology in 58-Year-Old Man
Aug 3, 2024, 10:56 AM
In a groundbreaking medical achievement, doctors in the United States have successfully implanted a fully mechanical titanium heart in a 58-year-old man. The heart, developed by BiVACOR, utilizes Maglev technology, which is also used in high-speed rail travel, to function effectively. This world-first implantation has kept the patient alive for days, marking a significant milestone in medical science. Experts believe the impact of this innovation will be tremendous, potentially revolutionizing the future of heart transplants and artificial organs.
View original story
Similar markets
Yes • 50%
No • 50%
1 • 25%
2-3 • 25%
4-5 • 25%
More than 5 • 25%
Yes • 50%
No • 50%
Infection • 25%
Device malfunction • 25%
Rejection • 25%
No major complications • 25%
Cleveland Clinic • 25%
Mayo Clinic • 25%
Johns Hopkins Hospital • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
